How to Get Mounjaro in the UK (2026 Guide)

What is Mounjaro (tirzepatide)?

Mounjaro is the brand name for tirzepatide, a weekly injection manufactured by Eli Lilly. It works as a dual GIP/GLP-1 receptor agonist — meaning it targets two hormone receptors simultaneously, making it more powerful than older GLP-1 drugs like Ozempic (semaglutide).

In clinical trials, tirzepatide reduced HbA1c by up to 2.5 percentage points in people with type 2 diabetes and produced average weight loss of 15–22% of body weight in people with obesity — results significantly better than any previously available medication in this class.

In the UK, Mounjaro is licensed for:

• Type 2 diabetes (as an addition to diet, exercise, and existing medication)
• Chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27–30) with at least one weight-related condition

Can I get Mounjaro on the NHS?

Yes — but access is restricted. As of 2026, NHS England has approved Mounjaro for type 2 diabetes via specific pathways. The criteria are:

For weight management without diabetes, NHS access to Mounjaro is currently being rolled out through specialist weight management services (tier 3 and tier 4). This is not yet widely available from your GP directly in most areas — eligibility varies significantly by NHS Integrated Care Board (ICB).

How to ask your GP about NHS Mounjaro

The most effective approach is to book a dedicated diabetes or weight management review appointment. Bring your most recent HbA1c reading, your current medication list, and your BMI. Ask specifically whether you meet local criteria for tirzepatide — your GP may refer you to a specialist if they believe you're eligible.

If you have been tracking your glucose readings, bringing 90 days of data is compelling evidence. You can generate a clean GP-ready summary using the free QumranHealth glucose tracker.

Private prescription options

If you do not qualify for NHS Mounjaro, or want to start sooner, private prescriptions are available from a range of UK online clinics and pharmacies. You do not need a GP referral for most private providers — they conduct their own online consultations.

The process at most private providers works like this:

1. Complete an online health questionnaire (BMI, medical history, current medications)
2. A UK-registered prescriber reviews your application — usually within 24–48 hours
3. If approved, your prescription is issued and your first pen is dispatched
4. Ongoing monitoring and prescription renewals are managed monthly or quarterly

Private Mounjaro costs vary significantly. See our full price comparison table for current pricing across all major UK providers — updated monthly.

Mounjaro dose escalation — what to expect

Mounjaro is started at a low dose and increased every four weeks to minimise side effects. The standard UK escalation schedule is:

Weeks	Dose	Notes
Weeks 1–4	2.5 mg once weekly	Starting dose — lowest available
Weeks 5–8	5 mg once weekly	First escalation
Weeks 9–12	7.5 mg once weekly	Mid-range — many patients stabilise here
Weeks 13–16	10 mg once weekly	Higher efficacy tier
Weeks 17–20	12.5 mg once weekly	Near-maximum
Week 21+	15 mg once weekly	Maximum dose — not everyone needs this

Not everyone progresses to 15 mg. Many people achieve excellent results at 7.5 mg or 10 mg. Your prescriber will guide your escalation based on how well you are tolerating the medication and how your glucose or weight responds.

The most common side effects — nausea, vomiting, reduced appetite — are most pronounced at each dose increase and typically improve within 1–2 weeks. Eating smaller portions and avoiding fatty foods at dose-change time helps significantly.

Monitoring your glucose on Mounjaro

If you have type 2 diabetes, regular blood glucose monitoring is strongly recommended when starting or changing your Mounjaro dose. This is because tirzepatide can lower glucose levels significantly — especially in the first 8 weeks — and your GP may need to adjust other diabetes medications (particularly sulphonylureas or insulin) to avoid hypoglycaemia.

Recommended monitoring frequency when on Mounjaro with type 2 diabetes:

• Fasting glucose every morning (before breakfast)
• Post-meal glucose 2 hours after your largest meal, 2–3 times per week
• HbA1c test every 3 months for the first year

If your fasting readings drop below 5.0 mmol/L consistently, or if you experience any reading below 4.0 mmol/L (hypoglycaemia), contact your GP or prescriber promptly. They may reduce your dose of other diabetes medications.

Tracking your readings in one place makes this much easier. The QumranHealth glucose tracker is free to use and generates a clean 90-day report you can share with your GP — including estimated HbA1c and trend analysis.

Key things to know before you start

• Mounjaro requires a prescription — it cannot legally be sold without one in the UK. Avoid any website that offers it without a proper consultation.
• It is not a quick fix — full glucose-lowering effects typically emerge over weeks 3–6 and continue improving with dose increases.
• Storage matters — Mounjaro pens must be kept at 2–8°C in a refrigerator. Do not freeze. Before injection, let the pen warm to room temperature for 30 minutes.
• Sharps disposal is required — needles must go in an approved yellow sharps bin, not household recycling. Local councils offer free collection.
• Tell your GP you are on Mounjaro — even if you obtained it privately, your GP needs to know so they can adjust other medications and flag it in your records.